07/09/09 Baltimore, Maryland “Something happened last week that I predicted many months ago,” reports our tech analyst Patrick Cox. “Big Pharma initiated a collaboration with one of the stem cell companies I recommended to my Breakthrough Technology Alert readers. The deal is to develop and sell drug-discovery technologies derived from two stem cell lines approved by the Bush administration.
“I don’t write this to crow about being right. I write this because it is critically important that you understand that this is just the tip of the iceberg. For anybody familiar with the way pharma interacts with disruptive startups, it was inevitable. New products from Big Pharma have slowed to a trickle in recent years. The old platforms have largely played out. Slowly, recognition is dawning on the world’s medical giants that it’s time to invest in the most disruptive technology the world has ever seen — stem cell technologies.
“Pharma is a lumbering behemoth. It may take years for the industry to change focus, but it spews cash wherever it turns. This recent deal is only the first.”
Sign Up for The Daily Reckoning e-letter and receive a copy of Bill Bonner's The Trade of The Decade report… at NO CHARGE.
We Value Your Privacy.
